Ameriprise
RXST icon

Ameriprise’s RxSight RXST Stock Holding History

Ameriprise’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Buy
+25,364
New +$211K ﹤0.01% 3918
2024
Q4 		– Sell
-104,441
Closed -$5.16M – 4151
2024
Q3 		$5.16M Buy
104,441
+61,034
+141% +$3.13M ﹤0.01% 2359
2024
Q2 		$2.61M Sell
43,407
-13,268
-23% -$758K ﹤0.01% 2743
2024
Q1 		$2.92M Buy
56,675
+4,345
+8% +$213K ﹤0.01% 2675
2023
Q4 		$2.11M Sell
52,330
-1,900
-4% -$55.7K ﹤0.01% 2841
2023
Q3 		$1.51M Buy
54,230
+37,325
+221% +$1.11M ﹤0.01% 2956
2023
Q2 		$487K Buy
+16,905
New +$376K ﹤0.01% 3447

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Ameriprise's RXST Position: Q1 2026 in Review

Ameriprise opened a new position in RxSight (RXST) in Q1 2026: 25,364 shares worth $156K. The stake represents ﹤0.01% of the portfolio and ranks #3918 among its holdings. This is a return to the name: Ameriprise previously reported a position in RXST as recently as Q3 2024.

Ameriprise first reported a position in RXST in Q2 2023 and has held it in 7 quarters since. The position peaked at $5.16M in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Ameriprise held 25,364 shares of RxSight worth $156K as of Q1 2026.
  • RxSight was a new Ameriprise position in Q1 2026.
  • RxSight made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3918 holding.
  • Ameriprise first reported a position in RxSight in Q2 2023 and has held it in 7 quarters since.
  • Ameriprise's RxSight position peaked at $5.16M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.